NetworkNewsBreaks – GC Pharma’s Promising Research, Shincheonji Church Plasma Drive Offer Ray of Hope for Latin American COVID-19 Patients
GC Pharma and Shincheonji Church are offering assistance for the Latin American countries ravaged by the COVID-19 pandemic. A recent breakthrough in GC Pharma’s COVID-19 research was achieved on Dec. 6, 2020, when a COVID-19 patient recovered after receiving GC Pharma’s blood plasma therapy. The therapy, GC5131, was developed by fractioning an antibody with the immunogenicity from the plasma of a recovered COVID-19 patient. Many Latin American hospitals already use GC Pharma’s IVIG-SN treatment to save patients from various illnesses, and this breakthrough may also open doors for GC Pharma’s blood plasma therapy to be administered to Latin American COVID-19…